Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye

Clinical Ophthalmology ◽

10.2147/opth.s44688 ◽

2013 ◽

pp. 1275 ◽

Author(s):

Karen Meerovitch ◽

Gail Torkildsen ◽

John Lonsdale ◽

Heidi Goldfarb ◽

Teresa Lama ◽

...

Keyword(s):

Clinical Trial ◽

Dry Eye ◽

Phase 2 ◽

Safety And Efficacy ◽

Phase 2 Clinical Trial ◽

Ophthalmic Solutions

Download Full-text

Ridinilazole for Clostridium difficile infections: safety and efficacy compared with vancomycin from the CoDIFy phase 2 clinical trial

10.26226/morressier.56d5ba27d462b80296c95f87 ◽

2016 ◽

Author(s):

Mark H. Wilcox

Keyword(s):

Clinical Trial ◽

Clostridium Difficile ◽

Phase 2 ◽

Safety And Efficacy ◽

Phase 2 Clinical Trial

Download Full-text

Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00126334-200301010-00004 ◽

2003 ◽

Vol 32 (1) ◽

pp. 18-29 ◽

Author(s):

Ian Sanne ◽

Peter Piliero ◽

Kathleen Squires ◽

Alexandra Thiry ◽

Steven Schnittman

Keyword(s):

Clinical Trial ◽

Comparative Trial ◽

Phase 2 ◽

Safety And Efficacy ◽

Phase 2 Clinical Trial ◽

Download Full-text

Efficacy and Safety of Diquafosol Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial

Ophthalmology ◽

10.1016/j.ophtha.2012.04.010 ◽

2012 ◽

Vol 119 (10) ◽

pp. 1954-1960 ◽

Author(s):

Yukihiro Matsumoto ◽

Yuichi Ohashi ◽

Hitoshi Watanabe ◽

Kazuo Tsubota

Keyword(s):

Clinical Trial ◽

Dry Eye ◽

Ophthalmic Solution ◽

Dry Eye Syndrome ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 2 Clinical Trial ◽

Diquafosol Ophthalmic Solution

Download Full-text

A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients

Case Medical Research ◽

10.31525/ct1-nct04273165 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Friedreich Ataxia ◽

Phase 2 ◽

Safety And Efficacy ◽

Phase 2 Clinical Trial

Download Full-text

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial

Leukemia ◽

10.1038/s41375-021-01210-8 ◽

2021 ◽

Author(s):

Enrico Tiacci ◽

Luca De Carolis ◽

Edoardo Simonetti ◽

Mara Merluzzi ◽

Antonio Bennati ◽

...

Keyword(s):

Clinical Trial ◽

Hairy Cell Leukemia ◽

Braf Inhibitor ◽

Phase 2 ◽

Cell Leukemia ◽

Pilot Phase ◽

Safety And Efficacy ◽

Phase 2 Clinical Trial

Download Full-text

GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection

Journal of Hepatology ◽

10.1016/s0618-8278(19)30141-0 ◽

2019 ◽

Vol 70 (1) ◽

pp. e81 ◽

Author(s):

Heiner Wedemeyer ◽

Katrin Schöneweis ◽

Pavel O. Bogomolov ◽

Natalia Voronkova ◽

Vladimir Chulanov ◽

...

Keyword(s):

Clinical Trial ◽

Interferon Alpha ◽

Phase 2 ◽

Safety And Efficacy ◽

Open Label Phase ◽

Phase 2 Clinical Trial ◽

Download Full-text

Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.9 ◽

2019 ◽

Vol 3 ◽

pp. S9

Author(s):

Zoe Draelos ◽

Fran Cook-Bolden ◽

Lawrence Green ◽

Eric Guenin ◽

Gina Martin ◽

...

Keyword(s):

Clinical Trial ◽

Patient Reported Outcomes ◽

Phase 2 ◽

Patient Reported ◽

Phase 2 Clinical Trial

Abstract not available.

Download Full-text

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Case Medical Research ◽

10.31525/ct1-nct04283669 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Neurofibromatosis Type ◽

Neurofibromatosis Type 2 ◽

Vestibular Schwannomas ◽

Phase 2 ◽

Phase 2 Clinical Trial

Download Full-text

Faculty Opinions recommendation of Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047842.497861 ◽

2006 ◽

Author(s):

David Sullivan

Keyword(s):

Clinical Trial ◽

Plasmodium Falciparum ◽

Combination Therapy ◽

Falciparum Malaria ◽

Plasmodium Falciparum Malaria ◽

Phase 2 ◽

Phase 2 Clinical Trial ◽

Uncomplicated Plasmodium Falciparum Malaria ◽

Randomized Phase 2

Download Full-text

Faculty Opinions recommendation of Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727784209.793552909 ◽

2018 ◽

Author(s):

Warren A Chow

Keyword(s):

Clinical Trial ◽

Macrophage Infiltration ◽

Phase 2 ◽

Pathway Activation ◽

Phase 2 Clinical Trial

Download Full-text